Cargando…

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis

PURPOSE: The purpose of this study was to determine whether pulmonary oligometastases from colorectal cancer have greater radioresistance than that of pulmonary oligometastases from other cancers and whether good local control can be achieved by dose escalation in stereotactic body radiotherapy. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jingu, Keiichi, Matsushita, Haruo, Yamamoto, Takaya, Umezawa, Rei, Ishikawa, Yojiro, Takahashi, Noriyoshi, Katagiri, Yu, Takeda, Kazuya, Kadoya, Noriyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Stereotactic Body Radiotherapy for Cancers of Various Organs-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111389/ https://www.ncbi.nlm.nih.gov/pubmed/30145943 http://dx.doi.org/10.1177/1533033818794936

Ejemplares similares

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes—A Review
por: Matsushita, Haruo, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy as an Alternative to Definitive Surgery in Cancers of Various Organs
por: Shibamoto, Yuta, et al.
Publicado: (2018)

A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer
por: Matsuo, Yukinori
Publicado: (2018)

Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer
por: Yamamoto, Takaya, et al.
Publicado: (2018)

Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute
por: Yamamoto, Takaya, et al.
Publicado: (2021)

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)

Pretreatment (18)F-fluorodeoxyglucose Uptake in the Lung Parenchyma Predicts Poor Survival After Stereotactic Body Radiation Therapy in Patients With Stage I Non-Small Cell Lung Cancer
por: Satoh, Yoko, et al.
Publicado: (2018)

Definitive Radiotherapy With SBRT or IMRT Boost for Breast Cancer: Excellent Local Control and Cosmetic Outcome
por: Shibamoto, Yuta, et al.
Publicado: (2018)

Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
por: Takeda, Kazuya, et al.
Publicado: (2021)

Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
por: Yamamoto, Takaya, et al.
Publicado: (2015)

The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy
por: Tasaka, Shun, et al.
Publicado: (2021)

Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
por: Yamamoto, Takaya, et al.
Publicado: (2022)

Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies
por: Kimura, Tomoki, et al.
Publicado: (2018)

Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
por: Takahashi, Noriyoshi, et al.
Publicado: (2016)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study
por: Yamamoto, Takaya, et al.
Publicado: (2022)

Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors
por: Yamamoto, Takaya, et al.
Publicado: (2014)

Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols-
por: Umezawa, Rei, et al.
Publicado: (2015)

Cardiac impacts of postoperative radiotherapy for breast cancer in Japanese patients
por: Segawa, Erika, et al.
Publicado: (2023)

Successful treatment with radiation therapy for desmoid-type fibromatosis with unilateral hydronephrosis: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2021)

Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccine
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study
por: Takeda, Kazuya, et al.
Publicado: (2022)

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy
por: Chang, Joe H., et al.
Publicado: (2016)

Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer
por: Seppälä, Jan, et al.
Publicado: (2016)

Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis
por: Francolini, Giulio, et al.
Publicado: (2022)

Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study
por: Umezawa, Rei, et al.
Publicado: (2020)

Longitudinal analyses and predictive factors of radiation-induced lung toxicity-related parameters after stereotactic radiotherapy for lung cancer
por: Yamamoto, Takaya, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy (SABR) lung fractionations locally in the COVID-19 era and the impact on dosimetry, resources, early toxicities, and the environment
por: Phelps, Lyndsey, et al.
Publicado: (2021)

Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
por: Francolini, Giulio, et al.
Publicado: (2022)

Assessment of myocardial metabolic disorder associated with mediastinal radiotherapy for esophageal cancer -a pilot study-
por: Umezawa, Rei, et al.
Publicado: (2015)

Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy
por: Kozumi, Maiko, et al.
Publicado: (2018)

Factors related to primary cancer death and non‐primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Comparison of acute gastrointestinal toxicities between 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy including prophylactic regions in chemoradiotherapy with S-1 for pancreatic cancer—importance of dose volume histogram parameters in the stomach as the predictive factors-
por: Umezawa, Rei, et al.
Publicado: (2022)

Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Brachytherapy for primary nasal vestibule cancer using Au-198 grains
por: Harada, Hinako, et al.
Publicado: (2022)

Pre-treatment Evaluation of Patients Eligible for Whole Brain Radiation Therapy: The Risk of Hippocampal Metastases in a Retrospective Study of 248 Cases at a Single Institution
por: Ishikawa, Yojiro, et al.
Publicado: (2023)

Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
por: Shirata, Yuko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r06tj2r6kvpb2q0tqrkskdv8ot